Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) have earned a consensus rating of “Buy” from the ten analysts that are covering the stock, MarketBeat reports. Ten research analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have issued ratings on the stock […]
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) have received an average rating of “Buy” from the ten brokerages that are covering the company, Marketbeat reports. Ten analysts have rated the stock with a buy rating. The average 12 month target price among brokerages that have covered the stock in the last […]
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) insider Scott Bizily sold 1,750 shares of the stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $25.45, for a total value of $44,537.50. Following the sale, the insider now directly owns 1,737 shares of the […]
4D Molecular Therapeutics (NASDAQ:FDMT) Announces Earnings Results, Beats Expectations By $0.07 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
4D Molecular Therapeutics (NASDAQ:FDMT) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPS etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.